Individualization of Propranolol Therapy
- 1 September 1974
- journal article
- Published by Elsevier in Medical Clinics of North America
- Vol. 58 (5) , 1063-1069
- https://doi.org/10.1016/s0025-7125(16)32102-2
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Disposition of propranolol VI. Independent variation in steady‐state circulating drug concentrations and half‐life as a result of plasma drug binding in manClinical Pharmacology & Therapeutics, 1973
- Pharmacodynamic Studies of Beta Adrenergic Antagonism Induced in Man by Propranolol and PractololJournal of Clinical Investigation, 1973
- Propranolol Inhibition of Renin SecretionNew England Journal of Medicine, 1972
- Effect of route of administration on the relationship between β‐adrenergic blockade and plasma propranolol levelClinical Pharmacology & Therapeutics, 1972
- Pharmacology of 4‐hydroxypropranolol, a metabolite of propranololBritish Journal of Pharmacology, 1971
- Plasma Propranolol Levels Associated with Suppression of Ventricular Ectopic BeatsBMJ, 1971
- Plasma Propranolol Levels in the Quantitative Assessment of -adrenergic Blockade in ManBMJ, 1970
- Central Hypotensive Activity of dl- and d-PropranololJournal of Pharmaceutical Sciences, 1970
- Metabolism of Propranolol (‘Inderal’), a Potent, Specific β-Adrenergic Receptor Blocking AgentNature, 1967
- Multicenter trial of propranolol in angina pectorisThe American Journal of Cardiology, 1966